A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.

Medicine (Baltimore) · 2015 · PMC4602870 · PMID 25997043

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

39 Our results suggest that anthocyanin supplementation reduced plasma MPO and showed a trend toward improvement in NAFLD fibrosis score.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Plasma levels of high-density lipoprotein-cholesterol increased moderately in both the groups, but this trend did not reach statistical significance across the 2 groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.